Eurofins-Cerep SA (EPA:ALECR)
France · Delayed Price · Currency is EUR 18,200
0.00 (0.00%)
Sep 1, 2025, 4:30 PM CET
Eurofins-Cerep Market Cap
Eurofins-Cerep has a market cap or net worth of €91.80 million as of September 5, 2025. Its market cap has decreased by -14.15% in one year.
Market Cap
91.80M
Enterprise Value
74.55M
Revenue
40.49M
Ranking
n/a
PE Ratio
12.83
Stock Price
€18,200.00
Market Cap Chart
Since January 5, 2015, Eurofins-Cerep's market cap has decreased from 1.18B to 91.80M, a decrease of -92.21%. That is a compound annual growth rate of -21.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 91.80M | -7.14% |
| Dec 31, 2024 | 98.86M | -21.60% |
| Dec 29, 2023 | 126.10M | 45.35% |
| Dec 23, 2021 | 86.76M | 32.31% |
| Dec 30, 2020 | 65.57M | 94.03% |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 118.56B |
| Sanofi | 105.02B |
| Sartorius Stedim Biotech | 16.79B |
| bioMérieux | 13.66B |
| Eurofins Scientific SE | 11.17B |
| Ipsen | 9.66B |
| ABIVAX Société Anonyme | 5.40B |
| Virbac | 2.74B |